GLICLAGLAZE MET is a specialized medication for managing type 2 diabetes, formulated to help control blood glucose levels efficiently. This treatment is part of a comprehensive approach to diabetes care that includes dietary changes, physical activity, and regular glucose monitoring.
Uses
GLICLAGLAZE MET is primarily used to:
Improve blood sugar control in adults with type 2 diabetes.
Reduce the risk of diabetes-related complications such as cardiovascular disease, nerve damage, and kidney dysfunction.
Assist in achieving target blood glucose levels as part of a broader diabetes management plan.
Composition
The active ingredients in GLICLAGLAZE MET include:
Glipizide: A sulfonylurea that stimulates insulin secretion from the pancreatic beta cells.
Metformin: A biguanide that decreases hepatic glucose production and improves insulin sensitivity.
This combination allows for effective control of blood glucose levels with a reduced risk of inducing hypoglycemia.
Dosage
Starting Dosage: The usual starting dose is one tablet taken twice daily with meals to reduce gastrointestinal side effects.
Maintenance Dosage: Depending on the patient's response, the healthcare provider may adjust the dosage.
Administration: Tablets should be taken whole, not split or chewed, to maintain the integrity of the medication release mechanisms.
Side Effects
Possible side effects of GLICLAGLAZE MET include:
Gastrointestinal disturbances such as nausea, vomiting, and diarrhea.
Hypoglycemia, particularly if taken without adequate food intake.
Skin reactions like rash or itching. Price
The cost of GLICLAGLAZE MET can vary based on the pharmacy, dosage, and whether it's covered by health insurance. Patients are encouraged to consult their pharmacy or insurance provider for specific pricing information.
Precautions
Kidney Function: Patients with renal impairment should use this medication cautiously, as metformin can accumulate in the body and increase the risk of lactic acidosis.
Alcohol Use: Alcohol can increase the effect of metformin on lactate metabolism and should be consumed in moderation.
Pregnancy and Breastfeeding: Safety in pregnancy and breastfeeding has not been fully established. Discuss potential risks and benefits with your healthcare provider.
Conclusion
GLICLAGLAZE MET is an effective medication for managing type 2 diabetes, offering benefits that extend beyond glucose control. Steris Healthcare Pvt Ltd, founded by a group of expert professionals in the pharmaceutical industry in February 2018, operates as Sterispharma. This company, which is based in Navi Mumbai, holds certifications from WHO, GMP, and ISO. Its commitment is to provide high-quality drugs at affordable prices to its customers throughout India, following the rigorous guidelines set by the WHO. Steris offers the convenience of an online pharmacy where customers can easily buy medicines and enjoy the benefit of home delivery. At Steris, the mission is to supply a wide array of healthcare products designed to meet the varied needs of the medical community. Whether it is advanced treatments, medications for rare conditions, or basic health necessities, Sterispharma strives to serve the healthcare industry’s broad demands. gynecology, Pediatrics, Dental care, and Dermatology. The extensive product lineup from Steris includes treatments for various health areas such as Cardiology, Asthma, Respiratory issues, Nasal conditions, Diabetes, Endocrinology, Gastroenterology, Orthopedics, Anti-infectives/antibiotics, General Medicine, Urology, Neurology, Nephrology, Oncology, Gynecology, Pediatrics, Dental care, and Dermatology.
For further information:
EMAIL: info@sterispharma.com / contact@sterispharma.com
CALL/WHATSAPP: 7877551268, 7849827488
,Metformin SR (500 m)
Submit Your Enquiry